1. Home
  2. KOD vs DOMO Comparison

KOD vs DOMO Comparison

Compare KOD & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • DOMO
  • Stock Information
  • Founded
  • KOD 2009
  • DOMO 2010
  • Country
  • KOD United States
  • DOMO United States
  • Employees
  • KOD N/A
  • DOMO N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • KOD Health Care
  • DOMO Technology
  • Exchange
  • KOD Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • KOD 795.5M
  • DOMO 707.1M
  • IPO Year
  • KOD 2018
  • DOMO 2018
  • Fundamental
  • Price
  • KOD $16.43
  • DOMO $12.41
  • Analyst Decision
  • KOD Buy
  • DOMO Buy
  • Analyst Count
  • KOD 7
  • DOMO 8
  • Target Price
  • KOD $19.29
  • DOMO $15.13
  • AVG Volume (30 Days)
  • KOD 964.2K
  • DOMO 591.7K
  • Earning Date
  • KOD 11-13-2025
  • DOMO 12-04-2025
  • Dividend Yield
  • KOD N/A
  • DOMO N/A
  • EPS Growth
  • KOD N/A
  • DOMO N/A
  • EPS
  • KOD N/A
  • DOMO N/A
  • Revenue
  • KOD N/A
  • DOMO $318,363,000.00
  • Revenue This Year
  • KOD N/A
  • DOMO $2.32
  • Revenue Next Year
  • KOD N/A
  • DOMO $2.72
  • P/E Ratio
  • KOD N/A
  • DOMO N/A
  • Revenue Growth
  • KOD N/A
  • DOMO N/A
  • 52 Week Low
  • KOD $1.92
  • DOMO $6.01
  • 52 Week High
  • KOD $21.17
  • DOMO $18.49
  • Technical
  • Relative Strength Index (RSI)
  • KOD 48.57
  • DOMO 32.97
  • Support Level
  • KOD $17.04
  • DOMO $12.65
  • Resistance Level
  • KOD $19.26
  • DOMO $14.06
  • Average True Range (ATR)
  • KOD 1.79
  • DOMO 0.55
  • MACD
  • KOD -0.40
  • DOMO -0.03
  • Stochastic Oscillator
  • KOD 5.00
  • DOMO 9.98

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: